Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor

Breast Cancer Research and Treatment

Volumn 49, Issue SUPPL. 1, 1998, Pages

  Goss, Paul E ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Aromatase inhibitor; Breast cancer; Review; Vorozole

Indexed keywords

AMINOGLUTETHIMIDE; ANDROGEN RECEPTOR; AROMATASE; AROMATASE INHIBITOR; CYTOCHROME P450; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MEGESTROL; PROGESTERONE RECEPTOR; VOROZOLE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER SURVIVAL; CELL CULTURE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONFERENCE PAPER; ENZYME INHIBITION; ESTROGEN BLOOD LEVEL; FEMALE; GRANULOSA CELL; HUMAN; MASTECTOMY; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RAT; TISSUE LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; RANDOMIZED CONTROLLED TRIALS; TRIAZOLES;

EID: 0031782776     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1006052923468     Document Type: Article

References (6)

1. Wouters W, De Coster R, Van Dun J et al.: Comparative effects of the arotnatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivo. J Steroid Biochem Mol Biol 37: 1049-1054, 1990
2. Vanden Bossche H, Willemsens G, Roels I et al.: R76713 and enantiomers selective, nonsteroidal inhibitors of the cytochromc P450-dependent oestrogen synthesis. Biochem Pharmacol 40: 1707-1718, 1990
3. Wouters W, De Coster R, Beerens D et al.: Potency and selectivity of the aromatase inhibitor R76713. A study in human ovarian, adipose stromal, testicular and adrenal cells. J Steroid Biochem 36: 57-65, 1990
4. Vorozole (R083842) Investigator's Brochure. Third edition. May 1995
5. De Coster R, Wouters W. Bowden CR et al: New non-steroidal aromatase inhibitors: focus on R76713. J Steroid Biochem Molec Biol 37: 335-341, 1990
6. Dowsett M, Stein RC, Mehta A et al.: Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients. Clin Endocrinol 32: 623-634, 1990